Marshfield Clinic Health System, Inc.

Marshfield Clinic Health System, Inc. is a non-profit healthcare organization based in Marshfield, Wisconsin, registered in SAM.gov as a corporate entity with tax-exempt status. The organization provides extensive public health research, medical testing, and scientific services to federal agencies, with a primary focus on epidemiological research, vaccine safety monitoring, and infectious disease analysis. Through its subsidiaries, including Marshfield Clinic, Inc. and Marshfield Clinic Research Institute, the organization has established itself as a critical partner for agencies like the Centers for Disease Control and Prevention (CDC) and the Department of Health and Human Services.

Marshfield Clinic Health System, Inc. has performed significant work through federal contract awards, predominantly with the CDC. Its contract work has included centralized molecular testing for SARS-CoV-2 and influenza viruses, epidemiologic assessments of Lyme disease diagnoses, serum repository maintenance, and vaccine effectiveness studies. Notable contracts include a $19.9 million CDC contract for COVID-19 molecular assessment, a $10.8 million contract for prospective COVID-19 community transmission research, and multiple task orders under the Vaccine Safety Datalink Project. These contracts consistently demonstrate no set-aside designations and involve collaborations with partners like the University of Wisconsin System, University of Arizona, and ABT Global LLC.

The organization's federal grant sub-awards reveal extensive research across diverse domains, including public health, agricultural health, child development, and occupational health. Key grant activities include studies on dairy farm worker microbiome exposure, children's respiratory research, autism spectrum disorder risk factors, and COVID-19 infection prevalence. Marshfield has worked with prime grantees such as the University of Wisconsin System, Washington University, Vanderbilt University Medical Center, and various state departments of health. Grant work often involves collaborative research, data collection, sample processing, and comprehensive epidemiological investigations spanning multiple research domains.

Marshfield Clinic holds a significant Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the CDC: the Vaccine Safety Datalink (VSD) Project. This master contract, with a potential value of $149 million, enables the CDC to conduct vaccine safety studies and rapid analyses. Under this vehicle, Marshfield has received multiple delivery orders, including a $3.76 million task order for vaccine safety data support through September 2027, a $1.6 million delivery order for vaccine safety data analysis, and several smaller task orders. These task orders consistently focus on providing scientific expertise, technical support, and data analysis to support the CDC's vaccine safety monitoring objectives.